1

Short-Acting Insulin Market will grow at highest pace owing to rising demand for personalized diabetes treatment

 News Discuss 
The short-acting insulin market is estimated to be valued at USD 10.00 Bn in 2025 and is expected to reach USD 14.35 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.3% from 2025 to 2032. https://gettr.com/post/p3l9dxp46af

Comments

    No HTML

    HTML is disabled


    Report Page

Who Upvoted this Story

Search

Published News